The effect of the GLP-1 receptor agonist liraglutide on heart rate and heart rate variability in patients with type-2 diabetes: a randomized double-blind placebo-controlled cross over study
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Odense University Hospital, Odense (Denmark)
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
